Barclays’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$6 | – | 5254 |
|
|
2025
Q1 | $6 | Buy |
+1
| New | +$9 | ﹤0.01% | 5188 |
|
|
2024
Q2 | – | Sell |
-2,706
| Closed | -$47K | – | 4860 |
|
|
2024
Q1 | $47K | Sell |
2,706
-2,608
| -49% | -$46.3K | ﹤0.01% | 4626 |
|
|
2023
Q4 | $68.1K | Buy |
5,314
+4,645
| +694% | +$108K | ﹤0.01% | 4719 |
|
|
2023
Q3 | $24.8K | Sell |
669
-745
| -53% | -$33.2K | ﹤0.01% | 4126 |
|
|
2023
Q2 | $56.9K | Sell |
1,414
-14,609
| -91% | -$826K | ﹤0.01% | 3778 |
|
|
2023
Q1 | $1.16M | Buy |
16,023
+4,526
| +39% | +$439K | ﹤0.01% | 2622 |
|
|
2022
Q4 | $943K | Sell |
11,497
-2,328
| -17% | -$243K | ﹤0.01% | 2855 |
|
|
2022
Q3 | $1.31M | Buy |
13,825
+12,961
| +1,500% | +$1.46M | ﹤0.01% | 2033 |
|
|
2022
Q2 | $168K | Sell |
864
-2,102
| -71% | -$343K | ﹤0.01% | 3534 |
|
|
2022
Q1 | $688K | Sell |
2,966
-6,362
| -68% | -$2.03M | ﹤0.01% | 2674 |
|
|
2021
Q4 | $3.67M | Sell |
9,328
-2,799
| -23% | -$1.18M | ﹤0.01% | 1938 |
|
|
2021
Q3 | $5.43M | Sell |
12,127
-188
| -2% | -$67.4K | ﹤0.01% | 1578 |
|
|
2021
Q2 | $4.79M | Buy |
12,315
+5,050
| +70% | +$1.8M | ﹤0.01% | 1607 |
|
|
2021
Q1 | $2.61M | Buy |
7,265
+4,482
| +161% | +$1.98M | ﹤0.01% | 2059 |
|
|
2020
Q4 | $1.36M | Sell |
2,783
-412
| -13% | -$190K | ﹤0.01% | 2542 |
|
|
2020
Q3 | $1.03M | Sell |
3,195
-1,055
| -25% | -$359K | ﹤0.01% | 2660 |
|
|
2020
Q2 | $1.55M | Buy |
4,250
+1,033
| +32% | +$261K | ﹤0.01% | 2359 |
|
|
2020
Q1 | $683K | Buy |
3,217
+582
| +22% | +$185K | ﹤0.01% | 3326 |
|
|
2019
Q4 | $1.08M | Buy |
2,635
+1,144
| +77% | +$394K | ﹤0.01% | 3599 |
|
|
2019
Q3 | $526K | Sell |
1,491
-1,976
| -57% | -$737K | ﹤0.01% | 4209 |
|
|
2019
Q2 | $1.74M | Buy |
3,467
+2,896
| +507% | +$2.04M | ﹤0.01% | 3086 |
|
|
2019
Q1 | $567K | Sell |
571
-1,082
| -65% | -$1.01M | ﹤0.01% | 3994 |
|
|
2018
Q4 | $1.44M | Buy |
1,653
+1,001
| +154% | +$930K | ﹤0.01% | 2744 |
|
|
2018
Q3 | $674K | Buy |
652
+533
| +448% | +$521K | ﹤0.01% | 4013 |
|
|
2018
Q2 | $110K | Sell |
119
-225
| -65% | -$242K | ﹤0.01% | 5181 |
|
|
2018
Q1 | $335K | Sell |
344
-3
| -0.9% | -$2.73K | ﹤0.01% | 4359 |
|
|
2017
Q4 | $158K | Sell |
347
-290
| -46% | -$107K | ﹤0.01% | 4887 |
|
|
2017
Q3 | $264K | Sell |
637
-35
| -5% | -$13.2K | ﹤0.01% | 4187 |
|
|
2017
Q2 | $235K | Buy |
672
+305
| +83% | +$118K | ﹤0.01% | 4232 |
|
|
2017
Q1 | $189K | Buy |
367
+20
| +6% | +$8.28K | ﹤0.01% | 4386 |
|
|
2016
Q4 | $121K | Buy |
347
+332
| +2,213% | +$141K | ﹤0.01% | 4612 |
|
|
2016
Q3 | $8K | Sell |
15
-177
| -92% | -$96.1K | ﹤0.01% | 5854 |
|
|
2016
Q2 | $108K | Buy |
192
+184
| +2,300% | +$88.3K | ﹤0.01% | 4350 |
|
|
2016
Q1 | $4K | Sell |
8
-20
| -71% | -$9K | ﹤0.01% | 5698 |
|
|
2015
Q4 | $18K | Buy |
28
+20
| +250% | +$15.1K | ﹤0.01% | 5214 |
|
|
2015
Q3 | $6K | Sell |
8
-3
| -27% | -$3.66K | ﹤0.01% | 5966 |
|
|
2015
Q2 | $14K | Buy |
11
+3
| +38% | +$3.44K | ﹤0.01% | 5878 |
|
|
2015
Q1 | $8K | Sell |
8
-11
| -58% | -$7.27K | ﹤0.01% | 6333 |
|
|
2014
Q4 | $12K | Buy |
+19
| New | +$11.6K | ﹤0.01% | 6611 |
|
Other funds holding ATRA
EC
RG
VPC
SCA
